Idexx Laboratories (IDXX) Operating Leases (2019 - 2026)

Idexx Laboratories' Operating Leases history runs 8 years deep, the most recent figure standing at $98.7 million for Q1 2026.

• In Q1 2026, Operating Leases fell 17.11% year-over-year to $98.7 million; the TTM figure through Mar 2026 stood at $98.7 million (down 17.11% YoY), while the FY2025 annual figure was $101.2 million, up 3.39% from the prior year.
• Operating Leases was $98.7 million for Q1 2026 at Idexx Laboratories, down from $101.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $133.5 million in Q2 2025 to a low of $89.6 million in Q1 2022.
• Historically, Operating Leases has averaged $106.2 million across 5 years, with a median of $101.2 million in 2022.
• Biggest YoY gain for Operating Leases was 30.32% in 2023; the steepest drop was 17.36% in 2023.
• A 5-year view of Operating Leases shows it stood at $101.2 million in 2022, then retreated by 1.55% to $99.7 million in 2023, then declined by 1.84% to $97.8 million in 2024, then climbed by 3.39% to $101.2 million in 2025, then dropped by 2.38% to $98.7 million in 2026.
• The last three Operating Leases figures came in at $98.7 million (Q1 2026), $101.2 million (Q4 2025), and $106.5 million (Q3 2025), per Business Quant data.